Valuation: DocMorris AG

Market Cap 51Cr 62Cr 54Cr 46Cr 87Cr 5.97TCr 89Cr 601.44Cr 234.98Cr 2.94TCr 232.78Cr 227.76Cr 10TCr P/E 2026 *
-6.61x
P/E 2027 * -13.2x
Enterprise Value 71Cr 87Cr 76Cr 65Cr 121.82Cr 8.33TCr 123.7Cr 839.04Cr 327.8Cr 4.1TCr 324.74Cr 317.74Cr 14TCr EV / Sales 2026 *
0.57x
EV / Sales 2027 * 0.53x
Free-Float
66.45%
Yield 2026 *
-
Yield 2027 * -
1 year 7.45
Extreme 7.454
10.24
3 years 7.45
Extreme 7.454
108.05
5 years 7.45
Extreme 7.454
425
10 years 7.45
Extreme 7.454
547
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2022
Director of Finance/CFO 56 01/10/2024
Chief Tech/Sci/R&D Officer - 01/11/2024
Director TitleAgeSince
Chairman 68 28/04/2022
Director/Board Member 53 23/05/2019
Director/Board Member 56 01/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
-27.18%-.--% - - 62Cr
-1.33%-0.59%-23.16%-31.29% 1.5TCr
-2.62%-0.60%-30.99%-36.86% 688.47Cr
+0.63%-2.90%-22.44%-8.50% 590.7Cr
-1.00%+4.56%-10.88%-30.58% 389.99Cr
+0.49%+1.44%-29.17%-47.75% 315.65Cr
-1.55%-0.92%+7.04%-32.10% 309.48Cr
+0.71%-7.44%-41.90%-20.28% 295.61Cr
+1.72%+3.47%-13.21%+3.25% 262.71Cr
+2.56%-0.17%+96.84% - 256.13Cr
Average -2.75%-1.03%-7.54%-25.52% 512.62Cr
Weighted average by Cap. -0.96%-0.99%-15.56%-27.44%

Financials

2026 *2027 *
Net sales 123.68Cr 151.42Cr 132.99Cr 113.49Cr 213.24Cr 15TCr 216.53Cr 1.47TCr 573.79Cr 7.17TCr 568.43Cr 556.18Cr 25TCr 138.89Cr 170.04Cr 149.35Cr 127.45Cr 239.47Cr 16TCr 243.16Cr 1.65TCr 644.36Cr 8.05TCr 638.34Cr 624.58Cr 28TCr
Net income -8.1Cr -9.92Cr -8.71Cr -7.43Cr -14Cr -955.08Cr -14Cr -96Cr -38Cr -469.55Cr -37Cr -36Cr -1.62TCr -4.37Cr -5.35Cr -4.7Cr -4.01Cr -7.53Cr -514.94Cr -7.65Cr -52Cr -20Cr -253.16Cr -20Cr -20Cr -875.31Cr
Net Debt 20Cr 24Cr 22Cr 18Cr 34Cr 2.36TCr 35Cr 237.6Cr 93Cr 1.16TCr 92Cr 90Cr 4.01TCr 24Cr 29Cr 25Cr 22Cr 41Cr 2.78TCr 41Cr 280.2Cr 109.47Cr 1.37TCr 108.45Cr 106.11Cr 4.73TCr
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
1,337
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
10.36CHF
Average target price
10.22CHF
Spread / Average Target
-1.36%

Quarterly revenue - Rate of surprise